October 30, 2018 Licensing, IP, and Legal

DefiniGEN licenses Broad Institute CRISPR-Cas9 gene editing technology for optimized metabolic disease drug development

Cambridge, UK – 30th October 2018: DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes. Broad Institute CRISPR-Cas9 technology will be combined with DefiniGEN’s best-in-class induced Pluripotent Stem Cell (iPSC)... Read more

October 29, 2018 M&A, Partnerships Microscopy

ZEISS and arivis AG intensify strategic partnership

Joint further development of 3D visualizations of multidimensional image data JENA/Germany, MUNICH/Germany, 2018-10-29. ZEISS and arivis have now expanded and deepened their cooperation, which began in 2014. The companies are pursuing the common goal of enabling new findings in life sciences and in materials research by improving the presentation and analysis of digital data. Modern... Read more

October 29, 2018 Clinical Research/Diagn. Licensing, IP, and Legal

Bio-Rad Receives U.S. FDA Clearance for the IH-Reader 24, Expanding the Company’s Offering for the Blood Typing Market

Date: 10/29/2018 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the IH-Reader 24, a semi-automated blood typing instrument designed for medium- to small-volume laboratories. A combination centrifuge and... Read more

October 29, 2018 Clinical Research/Diagn. M&A, Partnerships

MacroGenics and NanoString Enter Translational Research Collaboration to Identify and Develop Biomarkers in Immuno-Oncology

PDF Version Translational Research Initiative Will Use PanCancer IO 360 Panel to Identify Predictive Signatures for MGD013 SEATTLE, Oct. 29, 2018 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that MacroGenics(NASDAQ:MGNX) and NanoString have entered into a translational research agreement to identify and develop biomarkers for MacroGenics’ MGD013 program.... Read more

October 25, 2018 Lab Equipment Product Launch

Eppendorf presents first internally developed CO2 incubator

25.10.2018 | PRESS RELEASE Hamburg, October 2018 “Today´s cell culture requires more than technical solutions for optimized growth conditions and efficient contamination prevention.” says Eppendorf´s Business Manager for cell culture products Dr. Patrik Ferreira. “For several years, customers involved in Eppendorf´s development process have reported an increasing demand for devices that provide flexibility, support with... Read more

October 25, 2018 Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships

Foundational 10,000 Immunomes Project Uses Mass Cytometry to Establish a Reference Standard for the Human Immune System

PDF Version Providing the largest source of standardized, multi-omic immune data from healthy human subjects to accelerate translational research SOUTH SAN FRANCISCO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technology, today announced the publication of the 10,000 Immunomes Project (10KIP), a seminal human immune reference standard containing mass cytometry immune cell profiles,... Read more

October 25, 2018 Clinical Research/Diagn. Informatics & Software Product Launch

CrownBio Releases MuBase® 2.0. An Open Access Database of Immuno-Oncology Murine Models

October 25, 2018 Updates enhance user experience, provide comprehensive characterization data, and add new models (San Diego, Calif., Oct. 25 2018) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has released MuBase 2.0. MuBase is CrownBio’s proprietary, free-to-access online database featuring... Read more

October 24, 2018 Product Launch

Masterfully distilled

2018-10-24 | Corporate Every enthusiast of fermented and distilled fruits knows about distillation. However, this process is essential in the petroleum industry as well. The separation process divides the liquids into several “fractions” which differ in their respective boiling points. All fractions, be it with alcoholic beverages or with crude oil, have specific characteristics. To be... Read more

October 24, 2018 Clinical Research/Diagn.

Recently released: 2 new Ph. Eur. Reference standards Zoledronic acid monohydrate and Infliximab BRP, as well as 16 replacement batches Back

PRODUCTS AND SERVICES NEWS 24 OCTOBER 2018 STRASBOURG, FRANCE 2 new Ph. Eur. Reference Standards and 16 replacement batches Y0002020 Zoledronic acid monohydrate  and Y0002110 Infliximab BRP Y0000740 Adrenaline impurity mixture, T1410000 Tiabendazole , E2250000 Ethosuximide impurity A, R0800000Rifampicin quinone , Y0000026 Sumatriptan impurity mixture, M0500000 Mepyramine maleate, C1950000Chlortalidone, T1899990 Triamcinolone, B1158000 Bumetanide , Y0000272 Oxaliplatin impurity B, Y0000073 Cetyl palmitate, Y0001341 Oseltamivir impurity H, H0200000 Heparin sodium BRP, B0305000 Beclometasone dipropionate anhydrous, S0150000  Salbutamol sulfate and A0575000 Amiodarone hydrochloride Content of the European Pharmacopoeia catalogue... Read more